Results: Data of measured depth activity distributions were prepared using the measured depth activity data. Activity pencil beam kernels needed for the APB algorithm were constructed using the data of measured depth activity distributions and calculations in lateral direction. Gaussian form was used for the lateral distribution data to take the effect of multiple Coulomb scattering into consideration.
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Ion Beam Applications SA, Louvain-la-Neuve, Belgium Purpose or Objective: To improve precision of particle therapy, in vivo range verification is highly desirable. Methods based on prompt gamma rays emitted during treatment seem promising but have not yet been applied clinically. Here we report on the translational implementation as well as the worldwide first clinical application of prompt gamma imaging (PGI) based range verification.
Material and Methods:
Focused on the goal of translating a knife-edge shaped slit camera prototype into clinical operation, we first systematically addressed remaining challenges and questions. A robust energy calibration routine and corresponding quality assurance protocols were developed. Furthermore, the positioning accuracy of the system was determined. The slit camera, intentionally developed for pencil beam scanning, was applied for double scattered (DS) proton beams. Systematic phantom experiments with increasing complexity have been performed. In the next step, the knife-edge shaped slit camera was applied clinically to measure the spatial prompt gamma ray distribution during a proton treatment of a head and neck tumor for seven consecutive fractions. Inter-fractional variations of the prompt gamma profile were evaluated. For three fractions in-room control CTs were acquired and evaluated for dose relevant changes.
Results:
In translational phantom experiments it was shown that proton range shifts can be visualized with the camera system for DS proton irradiation, proving its applicability under conditions of increased neutron background. Moreover, prompt gamma profiles for single iso-energy layers were extracted by synchronizing time resolved measurements to the rotation of the range modulator wheel of the DS treatment system. Furthermore, the position precision of the slit camera has been determined to provisionally be 1.1 mm (2σ). With this preparatory work, the first clinical application of the PGI slit camera was successful. Based on the PGI information, inter-fractional global range variations were in the range of ±2 mm for all evaluated fractions. The results of the iso-energy layer resolved prompt gamma profile analysis were in consistence with the sum profile analysis. Also the control CT based dose reconstruction revealed negligible range variations of about 1.5 mm. No influence of DVH parameters for target volume and organs at risk was found.
Conclusion:
This work demonstrates for the first time that prompt gamma ray based range verification can be applied for clinical treatment of patients. Further plans include the continuation of the clinical study to perform systematic evaluations based on an appropriate patient number. With the translation from basic physics experiments into clinical operation, the authors are confident that a prompt-gamma ray based technology is capable of range verification and can be used in the near future for online quality assurance as well as in midterm for potential margin reduction. Purpose or Objective: The importance of MRI steadily increases in radiation oncology not only as multimodality imaging device but also as an implemented online imaging technology. Imaging using MRI shows advantages compared to CT or CBCT offering superior soft tissue contrast without additional dose. Also in particle beam therapy integrated MR guided treatment units have great potential. A complete understanding of the particle beam characteristics in the presence of magnetic fields is required. So far, studies in this area are limited.
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Material and Methods:
Protons (60-250MeV) and carbon ions (120-400MeV/u) in the clinically required energy range impinging on a phantom of 35x35x50cm³ size were simulated using the MC framework GATE 7. Homogeneous magnetic fields of 0.35T, 1T and 3T perpendicular to the initial beam axis were applied. The beam deflection, shape, and the energy spectrum at the Bragg peak area was analyzed. A numerical algorithm was developed for deflection curve generation solving the relativistic equations of motion taking into account the Lorentz force and particle energy loss. Additionally, dose variations on material boundaries induced by magnetic fields were investigated for 250MeV protons.
Results: Transverse deflections up to 99mm were observed for 250MeV protons at 3T. Deflections for lower field strengths (e.g. future hybrid open-MRI proton delivery systems) yielded 12mm for 0.35T and 34mm for 1T. A change in the dose distribution at the Bragg-peak region was observed for protons. Energy spectrum analysis showed an asymmetric lateral energy distribution. The different particle ranges resulted in a tilted dose distribution, see Fig.1 .The numerical algorithm successfully modeled the deflection curve, with a maximum deviation of 1.8% and calculation times of less than 5ms. For a 250MeV proton beam passing in a 3T field through multiple slabs (water-air-water), only a 4% local dose increase at the first boundary was observed in single voxels due to the electron return effect.
Fig1: Deformed 2D dose distribution at the Bragg peak area for a 250MeV proton beam in a 3T field Conclusion: Beam deflections in magnetic fields could be described by a numerical algorithm. The observed change in dose distribution in the Bragg-peak region has to be taken into account in future dose calculations. However, local dose changes due to boundary effects seem to be negligible for clinical applications. Current work in progress deals with the inclusion of magnetic field effects in a dose calculation algorithm for particles. Purpose or Objective: To test the ability of detecting small delivery errors of the Integral Quality Monitoring (IQM) device (iRT Systems GmbH, Koblenz, Germany), a system for online monitoring of Intensity Modulated Radiation Therapy (IMRT) treatments. To evaluate the correlation between the changes in the detector output signal induced by small delivery errors with other metrics, such as the γ passing rate and the DVH variations, which are commonly employed to quantify the deviations between calculated and actually delivered dose distributions.
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Material and Methods: IQM consists of a large area ionization chamber, with a gradient in the electrode plate separation, to be mounted on the treatment head, and a calculation algorithm to predict the signal based on the data received from the treatment planning system. The output of the ionization chamber provides a spatially dependent signal for each beam segment. 5 types of errors were induced in clinical IMRT step and shoot plans for head and neck (H&N), prostate and index quadrant planned with Pinnacle (Philips) with an Elekta Precise linac (6 MV), by modifying the number of delivered MUs and by introducing small deviations in leaf positions. The obtained dose distributions, both 'error free' (EF) and 'error induced' (EI) were delivered with the IQM system and the signal variations were recorded. EF and EI dose distributions were also compared in terms of: 1) 3D γ passing rate calculated on the entire dose volume; 2) 2D γ passing rate calculated on planar beam-by-beam dose distributions; 3) DVH metric, by calculating the differences for several significant DVH parameters. The correlation between IQM signal variations and 3D γ, 2D γ and DVH parameters was investigated.
Results: IQM system resulted to be extremely sensitive in detecting small delivery errors. Variations in beam MU down to 1 are detected by the system as well as changes in field size and positions down to 1 mm. In Table 1 the variations in the IQM signal are reported as an example for an H&N plan.
In Figure 1 the 2D γ per beam (1%/1mm, th10, local approach) and the PTV D95% and V95% are plotted vs the IQM signal variation for the same H&N example. A good correlation is observed thus suggesting that the IQM signal could be effectively used for quantifying delivery errors.
Conclusion:
IQM is capable of detecting small delivery errors in MU and leaves position and it shows a sufficient sensitivity for clinical practice. It also exhibits a good correlation with other metrics used to quantify the deviations between calculated and actually delivered dose distributions. Such
